Stock 300529 JAFRON BIOMEDICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Jafron Biomedical Co.,Ltd.

Equities

300529

CNE100002995

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-22 EDT 		5-day change 1st Jan Change
28.11 CNY -1.51% Intraday chart for Jafron Biomedical Co.,Ltd. -2.40% +26.45%
04-26 Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 CI
04-25 Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023
CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
CI
Jafron Biomedical Co.,Ltd.'s Equity Buyback announced on July 17, 2023, has closed with 24,242,904 shares, representing 3% for CNY 500 million.
CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Jafron Biomedical Co.,Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.
CI
Jafron Biomedical Co.,Ltd. authorizes a Buyback Plan.
CI
Jafron Biomedical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023
CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jafron Biomedical Co.,Ltd. Approves the Cash Dividend for 2022
CI
Jafron Biomedical Co.,Ltd. Announces Profit Distribution Proposal for 2022
CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Jafron Biomedical Co.,Ltd. Implements Final Cash Dividend (A Shares) for 2021, Payable on 10 June 2022
CI
Jafron Biomedical Co.,Ltd. Approves Profit Distribution
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300529 Stock
  4. News Jafron Biomedical Co.,Ltd.
  5. Highlights